Search Results 1171-1180 of 18412 for prednisone

1. Artificial Intelligence Assistant in Managing Uncomplicated Urinary Tract Infections in Women - Mayo Clinic

   Patient reports compromised immune system (examples include having HIV/AIDS or sickle cell disease, receiving chemotherapy or radiation, taking prednisone 20 mg ...

2. Meningitis - Diagnosis and treatment - Mayo Clinic

   Diagnosis. A healthcare professional can diagnose meningitis based on a medical history, a physical exam and certain tests. Common tests to diagnose ...

3. A Study for the Treatment of Primary Obesity - Mayo Clinic

   Immunosuppressive medications or systemic steroids (i.e., oral prednisone) within 6 months of Visit 1. Intranasal/inhaled steroids are acceptable. Unable or ...

4. Safety and Efficacy of B-cell Activating Factor Receptor (BAFFR)-based Chimeric Antigen Receptor T-cells in Subjects with Relapsed or Refractory BAFFR-expressing B-cell Hematologic Malignancies - Mayo Clinic

   Persons requiring systemic corticosteroids (>10 mg prednisone or equivalent per day) and/or other immunosuppressive therapy. Patients are allowed to use ...

5. Phase 1/2 Study of TP-0903 (an Inhibitor of AXL Kinase) in Patients With Previously Treated CLL - Mayo Clinic

   Have received >20 mg/day of prednisone and 0.1 mg/day of mineralocorticoids within 7 days prior to anticipated first dose. Have a corrected QT interval of ...

6. Ofloxacin (otic route) - Mayo Clinic

   Description. Ofloxacin belongs to the family of medicines called antibiotics. Ofloxacin otic solution is used to treat infections of the ear canal.

7. Mycobacterium Avium Complex Pulmonary Infections Systems Biology to Predict Progression and Treatment - Mayo Clinic

   Subjects with immunosuppressed conditions (e.g. known HIV infection) and/or immunosuppressing medications (e.g., chronic prednisone > 5mg/day for > 3 weeks ...

8. Daratumumab for Treatment of Proliferative Glomerulonephritis With Monoclonal Immune Deposits (PGNMID) - Mayo Clinic

   Patients receiving therapy with oral prednisone or glucocorticoid equivalent in the last 4 weeks. Patients treated with low dose oral prednisone or ...

9. Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults - Mayo Clinic

   About this study. This phase III trial compares the effect of usual treatment of chemotherapy and steroids and a tyrosine kinase inhibitor (TKI) to the same ...

10. A Multi-center Trial to Evaluate Multiple Regimens in Metastatic Pancreatic Cancer - Mayo Clinic

    Subjects receiving replacement therapy of 10 mg of prednisone (or the equivalent hydrocortisone dose) per day are eligible. - Receipt of live vaccines ...